Meeting News

Personalized therapy improves anaplastic thyroid cancer outcomes

November 6, 2019
CHICAGO — The era of untreatable anaplastic thyroid cancer is progressively being replaced by highly specific molecularbased personalized…
Meeting News

Research underway on essential genes in medullary thyroid cancer

November 6, 2019
CHICAGO — Investigators from The Ohio State University Comprehensive Cancer Center have initiated research on the proteomic gene alterations in…
Meeting News

ATA: Ethical, surgical, medical guidelines coming for anaplastic thyroid cancer

November 4, 2019
CHICAGO — The American Thyroid Association will publish new guidelines on ethical, surgical and medical considerations for patients with…
Meeting News

‘Rational combination therapies’ stand as the next step in thyroid cancer

November 4, 2019
CHICAGO — Bryan R. Haugen, MD, professor of medicine in the department of medicine-endocrinology, metabolism and diabetes at the University of…
Meeting News

Tall cell variant cutoff IDs highest risk papillary thyroid carcinomas

November 2, 2019
CHICAGO — Tall cell percentages between 30% and 49% appeared associated with higher tumor aggressiveness among patients with papillary thyroid…
Meeting News

Redifferentiation therapy resensitizes some radioactive iodine-refractory thyroid cancer

November 2, 2019
CHICAGO — Redifferentiation therapy with MEK inhibitor and/or BRAF inhibitor therapy resensitized some patients with metastatic radioactive…
Meeting News

Radiofrequency ablation viable option for some with thyroid cancer

November 2, 2019
CHICAGO — Radiofrequency ablation remains a safe and viable treatment option for certain patients with thyroid cancer, according to a presenter…
Meeting News

Apatinib shows activity in radioactive iodine-refractory differentiated thyroid cancer

November 2, 2019
CHICAGO — Apatinib demonstrated encouraging clinical activity among Chinese patients with progressive radioactive iodine-refractory…
Meeting News

Thyroid cancer expert receives Paul Starr Award

November 1, 2019
CHICAGO — Douglas S. Ross, MD, co-director of Thyroid Associates at Massachusetts General Hospital, received the 2019 Paul Starr Award during…
Meeting News

Pathway key to BRAF V600E-mediated papillary thyroid cancer progression

October 31, 2019
CHICAGO — The Wnt/beta-catenin signaling pathway may play an important role in the progression of BRAF V600E-mediated papillary thyroid…